Published on

Clinical Toxicology — Strychnine

1. Overview

Strychnine is a highly toxic plant-derived alkaloid that causes marked excitation of motor neurons by blocking inhibitory glycine receptors.

Poisoning is uncommon but potentially rapidly fatal.

The characteristic syndrome consists of repeated, intensely painful generalized muscle spasms, frequently triggered by minor sensory stimulation.

Patients may remain conscious and aware throughout the episodes, without the postictal confusion typical of generalized epileptic seizures.

Severe poisoning can produce:

  • Generalized tonic muscle contractions.
  • Opisthotonos.
  • Trismus and facial grimacing.
  • Respiratory muscle spasm.
  • Hypoventilation and asphyxia.
  • Hyperthermia.
  • Severe lactic acidosis.
  • Rhabdomyolysis.
  • Acute kidney injury.
  • Cardiovascular collapse.

There is no specific antidote.

Treatment requires a low-stimulation environment, rapid pharmacologic control of spasms, appropriate airway and ventilatory support, and management of systemic complications.

Early intensive supportive care can be lifesaving even after severe exposure.

2. Sources and forms

Natural sources

Strychnine occurs naturally in several plants of the genus Strychnos.

Important examples include:

Strychnos nux-vomica: The principal traditional source of strychnine, commonly called nux vomica.

Strychnos ignatii: Historically used in herbal preparations.

Strychnos tiente: Associated with certain traditional arrow-poison preparations.

The seeds and other plant materials may contain strychnine and related alkaloids, including brucine.

Traditional medicines

Strychnine-containing plants have been used in some traditional medical systems for pain, weakness, paralysis, and other conditions.

Products may be sold under names such as nux vomica or maqianzi.

The amount of strychnine may vary considerably with the source and preparation.

A traditional or herbal product should not be assumed safe because it is naturally derived.

Pesticides

Strychnine has historically been used in rodenticides and other animal-control baits.

Its use has been substantially restricted in many jurisdictions.

In the United States, certain pesticide applications have continued under federal and state regulatory controls.

Product availability and permitted uses should be verified against current registration and labeling.

Illicit drug contamination

Strychnine has been identified in unusual cases involving contaminated or adulterated illicit substances.

Potential routes include ingestion, intranasal exposure, and injection.

However, strychnine should not be presumed to be a common adulterant of modern illicit drug supplies without specific evidence.

Laboratory exposure

Strychnine may be present in research and chemical laboratories.

Accidental inhalation, ingestion, or contamination can occur if appropriate controls are absent.

Historical medicines

Older medicinal preparations occasionally contained small amounts of strychnine.

These are not appropriate contemporary treatments and may still be encountered in stored collections or outdated medicine supplies.

3. Mechanism of toxicity

Normal glycine function

Glycine is an important inhibitory neurotransmitter in the spinal cord and brainstem.

Activation of glycine receptors allows chloride ion conductance, reducing the excitability of postsynaptic neurons.

This inhibitory system normally prevents excessive motor-neuron activation.

Strychnine action

Strychnine acts as a competitive antagonist at glycine receptors.

Blocking glycine-mediated inhibition permits excessive motor-neuron excitation.

Minor sensory signals may then trigger widespread, uncontrolled muscle contractions.

Anatomical distribution

The spinal cord and brainstem are particularly important sites of toxicity.

Motor neurons become highly responsive to auditory, visual, tactile, and other stimuli.

Clinical consequence

The patient develops exaggerated reflexes and powerful generalized spasms.

These movements are often described as strychnine seizures, but they are not necessarily caused by abnormal cortical electrical activity.

Consciousness

Because cortical consciousness can initially remain intact, patients may experience severe fear and pain while unable to control their movements or breathing.

Respiratory failure

Spasm of the diaphragm, chest wall, and other respiratory muscles can prevent effective ventilation.

Hypoxia and cerebral injury may follow rapidly.

4. Toxic dose

Strychnine has a narrow margin between exposure and severe toxicity.

Very small quantities can be dangerous.

Human toxicity

Historical reports describe severe poisoning and death after relatively small amounts of pure strychnine.

However, a precise universal lethal dose cannot be established.

Outcome depends on:

  • Amount absorbed.
  • Route of exposure.
  • Formulation.
  • Patient age and body size.
  • Speed of treatment.
  • Ability to maintain ventilation.

Pediatric exposure

Children may develop serious toxicity after small ingestions.

Any credible pediatric exposure requires urgent assessment.

Important correction

Historical dose estimates should not be interpreted as safe thresholds below which poisoning cannot occur.

The exact amount ingested is often uncertain, particularly with plant material and pesticide formulations.

5. Toxicokinetics

Absorption

Strychnine is absorbed rapidly after ingestion.

Clinical effects commonly begin within 15–60 minutes.

Very severe exposure may produce symptoms earlier.

Delayed presentations

Delayed onset has also been reported, particularly after ingestion of plant seeds or other preparations with unpredictable gastrointestinal release.

Therefore, the absence of symptoms during the first hour does not reliably exclude toxicity.

Distribution

Strychnine enters tissues and reaches the central nervous system.

Metabolism

It is primarily metabolized in the liver.

Elimination

The clinical toxic effects may resolve relatively quickly after successful supportive care.

However, severe cases can have prolonged complications caused by hypoxia, muscle injury, or organ dysfunction.

Clinical principle

The duration of hospitalization should reflect both residual neurotoxicity and complications arising during the acute episode.

6. Epidemiology

Strychnine poisoning is rare in contemporary U.S. clinical practice.

Reported exposures involve:

  • Accidental access to pesticides.
  • Intentional self-poisoning.
  • Traditional herbal preparations.
  • Unusual illicit drug exposures.
  • Laboratory incidents.
  • Deliberate poisoning of another person.

Although uncommon, poisoning remains important because deterioration can be extremely rapid.

The rarity of exposure also increases the risk of delayed recognition.

7. Clinical presentation

Early symptoms

Patients may initially develop:

  • Anxiety.
  • Apprehension.
  • Restlessness.
  • Heightened sensory awareness.
  • Increased reflex responses.
  • Muscle twitching.
  • Stiffness.
  • Difficulty relaxing.

Generalized spasms

The characteristic manifestation is sudden, powerful contraction of multiple skeletal muscle groups.

Spasms are often extremely painful.

Stimulus sensitivity

Episodes may be precipitated by:

  • Touch.
  • Noise.
  • Bright light.
  • Movement.
  • Clinical examination.
  • Intravenous procedures.
  • Airway manipulation.

Even minor stimulation may provoke another episode.

Intermittent course

Patients may experience brief periods of relative muscular relaxation between episodes.

However, recurrent spasms can occur with little warning.

Consciousness

Patients frequently remain alert during early episodes.

Postictal phase

A typical prolonged postictal period is absent unless cerebral hypoxia, medication effects, or another complication develops.

The combination of painful generalized spasms, preserved consciousness, and marked stimulus sensitivity is strongly suggestive of strychnine poisoning.

8. Characteristic musculoskeletal findings

Opisthotonos

Powerful contraction of the neck and back muscles may cause extreme arching of the spine.

Trismus

Jaw-muscle contraction may produce difficulty opening the mouth.

Risus sardonicus

Facial muscle contraction may create a fixed grimacing expression.

Limb posturing

Powerful tonic contractions can produce extension or flexion of the limbs.

Generalized rigidity

The body may become extremely rigid during a spasm.

Complications

Violent muscular contractions can produce:

  • Muscle tears.
  • Rhabdomyolysis.
  • Joint injury.
  • Rare fractures.
  • Pressure-related injury.

Important distinction

These physical findings can resemble tetanus, but their onset and pattern are different.

9. Respiratory complications

Respiratory compromise is the principal immediate cause of death.

Mechanisms

Respiratory failure may occur through:

  • Spasm of respiratory muscles.
  • Inability to expand the chest.
  • Upper-airway compromise.
  • Aspiration.
  • Exhaustion after repeated contractions.
  • Secondary hypoxic neurologic injury.

Early warning signs

Concerning findings include:

  • Increasing frequency of spasms.
  • Difficulty speaking or breathing between episodes.
  • Cyanosis.
  • Inadequate ventilation.
  • Reduced responsiveness.
  • Hypercapnia.
  • Hypoxemia.

Rapid deterioration

Respiratory arrest may occur suddenly during a severe generalized spasm.

Clinical implication

Do not wait for a patient to become profoundly hypoxemic before preparing for advanced airway management.

10. Cardiovascular manifestations

Sympathetic activation

Severe pain, fear, muscular exertion, and hypoxia may produce:

  • Tachycardia.
  • Hypertension.
  • Diaphoresis.
  • Increased oxygen demand.

Severe toxicity

Repeated spasms and respiratory failure may cause:

  • Hypotension.
  • Dysrhythmias.
  • Myocardial ischemia.
  • Cardiac arrest.

Pathophysiology

Cardiovascular abnormalities are usually secondary to muscular activity, catecholamine release, metabolic disturbances, or hypoxia.

Clinical principle

A dysrhythmia should prompt urgent assessment of ventilation, acid-base status, and electrolytes in addition to routine cardiac treatment.

11. Metabolic complications

Lactic acidosis

Repeated generalized muscle contractions generate large amounts of lactate.

Severe metabolic acidosis may develop rapidly.

Hypoxia

Respiratory muscle spasm further increases lactate production by limiting oxygen delivery.

Hyperthermia

Sustained skeletal muscle activity generates excessive heat.

Temperature may become dangerously elevated.

Electrolyte abnormalities

Severe poisoning may produce changes in:

  • Potassium.
  • Calcium.
  • Phosphate.
  • Magnesium.

The pattern depends on muscle injury, kidney function, and treatment.

Rhabdomyolysis

Muscle breakdown can cause:

  • Elevated creatine kinase.
  • Myoglobinuria.
  • Hyperkalemia.
  • Acute kidney injury.

Clinical implication

Persistent acidosis after apparent spasm control should prompt evaluation for ongoing hypoperfusion, hypoxia, or another complication.

12. Acute kidney injury

Kidney injury is an important complication of severe poisoning.

Mechanisms

Potential causes include:

  • Rhabdomyolysis.
  • Myoglobin-mediated tubular injury.
  • Dehydration.
  • Hypotension.
  • Severe metabolic disturbances.

Clinical findings

Patients may develop:

  • Dark urine.
  • Oliguria.
  • Elevated creatinine.
  • Electrolyte abnormalities.

Monitoring

Serial urine output, kidney function, creatine kinase, and electrolyte measurements are appropriate after major muscle activity.

Treatment

Provide carefully titrated intravenous fluids and correct systemic complications.

Renal replacement therapy may be required for conventional indications such as refractory hyperkalemia, severe metabolic complications, or advanced kidney failure.

13. Differential diagnosis

Tetanus

Tetanus produces muscle rigidity, trismus, and stimulus-triggered spasms.

However, it usually develops days after exposure and often features persistent muscle rigidity between spasms.

Strychnine poisoning more typically has abrupt onset after exposure and periods of relative relaxation between episodes.

Generalized epileptic seizures

Epileptic convulsions are commonly associated with impaired awareness and a postictal period.

In strychnine poisoning, consciousness may remain intact.

Serotonin toxicity

Serotonin toxicity can cause hyperreflexia, clonus, rigidity, agitation, and hyperthermia.

A serotonergic medication exposure and the presence of clonus may favor serotonin toxicity.

Neuroleptic malignant syndrome

Usually follows exposure to dopamine antagonists or withdrawal of dopaminergic therapy.

The onset is generally slower than strychnine poisoning.

Acute dystonic reactions

Drug-induced dystonia may produce severe posturing or abnormal neck and facial movements.

However, the widespread, painful, stimulus-triggered spasms of strychnine poisoning are distinctive.

Other considerations

Additional possibilities include:

  • Hypocalcemic tetany.
  • Severe stimulant toxicity.
  • Hyperekplexia.
  • Stiff-person spectrum disorders.
  • Intracranial disease.
  • Other toxic exposures.

Diagnostic principle

Preserved awareness during dramatic generalized muscular activity should prompt consideration of a toxic or neuromuscular cause rather than automatically diagnosing epilepsy.

14. Diagnostic evaluation

Diagnosis is primarily clinical.

Exposure history

Identify:

  • Suspected substance.
  • Product name.
  • Source of exposure.
  • Estimated amount.
  • Route.
  • Time of exposure.
  • Other substances involved.

Ask about traditional medicines, pest-control products, stored chemicals, and unusual drug exposures.

Examination

Assess airway and ventilation first.

Observe muscle activity, consciousness, reflexes, and the relationship between spasms and external stimuli.

Avoid unnecessary handling.

Essential investigations

In a symptomatic patient, consider:

  • Bedside glucose.
  • Electrolytes.
  • Creatinine.
  • Creatine kinase.
  • Blood gas.
  • Lactate.
  • ECG.
  • Urinalysis.

Additional investigations

Depending on severity, consider:

  • Calcium.
  • Magnesium.
  • Phosphate.
  • Liver enzymes.
  • Troponin.
  • Coagulation studies.
  • Acetaminophen and salicylate concentrations after intentional or uncertain ingestion.

Serum strychnine concentrations

Specialized analytical testing may confirm exposure.

However, strychnine concentrations are not routinely available quickly enough to guide emergency treatment.

Clinical limitation

Do not delay treatment while waiting for toxicologic confirmation.

15. Initial emergency management

Immediate priorities

Strychnine poisoning is a time-critical emergency.

The principal goals are to:

  1. Minimize sensory stimulation.
  2. Control muscle spasms.
  3. Maintain oxygenation and ventilation.
  4. Prevent hyperthermia and muscle injury.
  5. Treat metabolic and cardiovascular complications.

Low-stimulation environment

Place the patient in a quiet setting.

Dim unnecessary lighting.

Limit nonessential examinations and procedures.

Explain interventions calmly when the patient remains conscious.

Airway preparation

Provide appropriate monitoring and establish readiness for advanced airway management.

Intravenous access

Obtain vascular access while minimizing unnecessary stimulation.

Poison-center consultation

Contact a regional poison control center or medical toxicologist immediately.

16. Benzodiazepines

Benzodiazepines are first-line pharmacologic treatment.

They enhance GABA-A receptor-mediated inhibition and reduce the uncontrolled motor activity associated with glycine receptor blockade.

Common agents

Options include:

  • Diazepam.
  • Lorazepam.
  • Midazolam.

Administration

Intravenous administration allows rapid treatment and titration.

Repeated doses may be necessary.

Monitoring

Assess:

  • Spasm frequency.
  • Respiratory effort.
  • Oxygenation.
  • Blood pressure.
  • Sedation depth.

Important limitation

Severe poisoning may require large cumulative sedative doses.

Respiratory depression from treatment must be anticipated.

Clinical principle

Adequate suppression of recurrent muscle spasms is essential because continued muscular activity can cause lethal respiratory and metabolic complications.

17. Refractory spasms

Persistent muscle activity

Patients whose spasms continue despite appropriate benzodiazepine treatment require rapid escalation.

Propofol

Propofol may be used in a controlled critical-care setting, particularly when intubation and mechanical ventilation are required.

Barbiturates

Phenobarbital or other barbiturates may be considered as additional sedative agents.

Phenytoin

Phenytoin is not a preferred treatment for the characteristic muscle spasms of strychnine poisoning.

Its sodium-channel-blocking antiseizure activity does not directly address the primary mechanism of toxin-induced motor-neuron disinhibition.

Clinical implication

Repeated ineffective administration of conventional antiseizure medications should not delay adequate sedation, airway protection, or neuromuscular blockade when necessary.

18. Neuromuscular blockade

Indications

Neuromuscular paralysis may be necessary when:

  • Severe generalized spasms persist.
  • Ventilation is inadequate.
  • Hyperthermia is worsening.
  • Severe acidosis is developing.
  • Muscular activity cannot be controlled safely with sedation alone.

Agents

Nondepolarizing neuromuscular blockers, such as rocuronium, may be used in appropriately equipped critical-care settings.

Ventilation

Patients receiving neuromuscular blockade require endotracheal intubation and mechanical ventilation.

Sedation and analgesia

Neuromuscular blockers provide paralysis but do not provide sedation, analgesia, or loss of consciousness.

Because strychnine-poisoned patients may remain aware, adequate sedation and analgesia are mandatory throughout paralysis.

Monitoring

Monitor ventilation, circulation, temperature, metabolic abnormalities, and clinical evidence of recovery.

Where true epileptic activity is also suspected, EEG may be useful because neuromuscular paralysis can conceal visible convulsions.

19. Airway management

Early intubation

Endotracheal intubation should be considered early in patients with severe or recurrent generalized spasms.

Challenges

Jaw rigidity, opisthotonos, and recurrent contractions may make airway management difficult.

Preparation

Intubation should be performed by clinicians experienced in managing difficult airways, with appropriate sedative and paralytic medications available.

Oxygen and ventilation

Provide oxygen and assisted ventilation as indicated.

Aspiration prevention

Patients are at risk of aspiration because of vomiting and impaired airway protection.

Clinical priority

Securing ventilation and controlling muscular activity take precedence over gastrointestinal decontamination.

20. Management of hyperthermia

Mechanism

Hyperthermia results mainly from intense skeletal muscle activity.

Treatment

Rapidly control muscle spasms and provide active external cooling when temperature is dangerously elevated.

Cooling options may include:

  • Evaporative cooling.
  • Cooling blankets.
  • Ice packs.
  • Other appropriate critical-care cooling measures.

Antipyretics

Conventional antipyretics such as acetaminophen are generally ineffective for toxin-related heat production caused by muscular activity.

Important principle

The definitive treatment of strychnine-related hyperthermia is control of muscle activity combined with active cooling.

21. Gastrointestinal decontamination

Induced vomiting

Do not induce vomiting.

Ipecac and other emetic methods are contraindicated because severe spasms, respiratory compromise, and aspiration can develop abruptly.

Activated charcoal

A single dose of activated charcoal may be considered after a substantial recent ingestion.

However, charcoal should be administered only when the airway is protected and muscular activity is controlled.

Clinical limitation

Charcoal is not a substitute for rapid sedation and respiratory support.

Gastric lavage

Routine gastric lavage is not recommended.

It can stimulate severe contractions and increase the risk of aspiration.

Exceptional circumstances

In an unusual, immediately life-threatening ingestion presenting very early, gastrointestinal lavage might be considered by a medical toxicologist after airway protection and control of muscle activity.

The evidence of benefit is limited.

Multiple-dose activated charcoal

There is insufficient clinical evidence to recommend multiple-dose activated charcoal routinely.

Important correction

The historical recommendation to perform gastric lavage automatically within one hour of a large ingestion is no longer appropriate.

22. Enhanced elimination

Hemodialysis

Hemodialysis is not considered an effective routine method for removing strychnine.

Its distribution characteristics limit extracorporeal clearance.

Hemoperfusion

There is no established routine role for hemoperfusion.

Forced diuresis

Forced diuresis is not recommended.

Urinary acidification

Urinary acidification is obsolete and potentially harmful.

It may worsen systemic acidosis and kidney injury.

Kidney failure

Renal replacement therapy may nevertheless be necessary for complications of acute kidney injury.

Clinical principle

Extracorporeal kidney support should be used for conventional clinical indications, not routinely to accelerate strychnine elimination.

23. Rhabdomyolysis management

Recognition

Repeated severe muscle contractions can rapidly increase creatine kinase concentrations.

Initial treatment

Control spasms immediately.

Provide intravenous fluids according to volume status, urine output, and cardiac and kidney function.

Electrolytes

Monitor and treat hyperkalemia and other abnormalities.

Urine alkalinization

Routine urine alkalinization has no established outcome benefit for strychnine-associated rhabdomyolysis.

Monitoring

Serial laboratory evaluation is necessary because muscle injury may evolve after the initial neurologic toxicity has been controlled.

24. Cardiovascular support

Tachycardia and hypertension

These often improve as pain, agitation, and spasms are controlled.

Hypotension

Evaluate for hypoxia, acidosis, dehydration, myocardial dysfunction, and treatment-related effects.

Provide carefully titrated fluids as indicated.

Persistent shock

A vasopressor such as norepinephrine may be used when clinically appropriate.

Dysrhythmias

Treat according to current resuscitation guidelines.

Correct hypoxemia and electrolyte disturbances.

Cardiac arrest

Provide immediate advanced life support while addressing the underlying poisoning.

25. Other exposure routes

Inhalation

Strychnine-containing dust or aerosol may be absorbed through the respiratory tract.

Remove the patient from the contaminated area.

Provide appropriate respiratory support.

Skin exposure

Remove contaminated clothing.

Wash affected skin thoroughly with soap and water.

Eye exposure

Irrigate exposed eyes promptly with clean water for approximately 15 minutes.

Injection

Injected strychnine can cause rapid systemic poisoning.

Gastrointestinal decontamination is irrelevant.

Treatment focuses on sedation, ventilation, and management of complications.

Responder safety

When contamination involves powder or an unknown chemical mixture, rescuers should avoid secondary exposure and follow appropriate hazardous-materials procedures.

26. Pregnancy and lactation

Pregnancy

Human pregnancy data are limited.

Severe maternal toxicity can cause hypoxemia, acidosis, hyperthermia, and cardiovascular instability, all of which may threaten fetal health.

Animal data

Reproductive toxicity has been reported in animal investigations.

These findings do not establish a precise human fetal risk.

Management

Maternal stabilization is the priority.

Necessary sedation, airway management, and critical-care treatment should not be withheld because of pregnancy.

Obstetric assessment should be arranged according to gestational age and maternal condition.

Lactation

Human lactation data are inadequate.

A patient with suspected strychnine exposure should not continue exposure to the source.

Breastfeeding decisions after significant poisoning require individualized assessment and toxicology advice.

27. Occupational exposure limits

The NIOSH Pocket Guide lists:

OSHA permissible exposure limit: 0.15 mg/m³ as an eight-hour time-weighted average.

NIOSH recommended exposure limit: 0.15 mg/m³ as a time-weighted average.

NIOSH immediately dangerous to life or health concentration: 3 mg/m³.

Interpretation

These values apply to workplace airborne exposure assessment.

They are not thresholds for oral toxicity and must not be used to estimate the safety of ingested strychnine.

Workplaces handling strychnine should use appropriate engineering controls, protective equipment, labeling, and exposure-response procedures.

28. Observation and disposition

Credible exposure without symptoms

Because severe toxicity can develop rapidly and occasionally be delayed, patients with credible potentially significant exposure require medical observation.

A contemporary clinical reference recommends approximately 12 hours of observation for asymptomatic exposures.

This should be individualized according to:

  • Route.
  • Formulation.
  • Estimated amount.
  • Time since exposure.
  • Reliability of the history.
  • Potential delayed absorption.

Symptomatic patients

Any patient with muscle twitching, hyperreflexia, anxiety associated with suspected poisoning, or other early toxic findings requires urgent reassessment.

Hospital admission

Admission is appropriate for clinically significant symptoms, recurrent spasms, metabolic abnormalities, or complications requiring continued monitoring.

Intensive care

ICU care is necessary for:

  • Generalized spasms.
  • Respiratory compromise.
  • Severe acidosis.
  • Hyperthermia.
  • Rhabdomyolysis with systemic complications.
  • Kidney injury.
  • Hemodynamic instability.
  • Need for deep sedation or paralysis.

Discharge

Discharge requires:

  • Completion of an appropriate observation period.
  • No evolving neuromuscular toxicity.
  • Normal and stable ventilation.
  • Stable vital signs.
  • Resolution of clinically significant metabolic abnormalities.
  • Appropriate assessment of possible delayed muscle or kidney injury.
  • A safe follow-up plan.

Intentional poisoning requires an appropriate mental health and safety assessment.

A universal four- to six-hour discharge rule should not be retained.

29. Expected course and prognosis

Early deterioration

Severe toxicity may progress to respiratory arrest within minutes of the onset of generalized spasms.

Recovery

When muscular activity and ventilation are controlled promptly, neurologic toxicity often improves substantially during the first 24 hours.

Severe complications

Patients with rhabdomyolysis, acute kidney injury, aspiration, or hypoxic brain injury may require prolonged hospitalization.

Long-term outcomes

Most survivors who receive timely treatment and avoid severe secondary injury recover without major long-term neurologic effects.

Mortality

Strychnine poisoning can be rapidly fatal without treatment.

However, recovery has been documented after very large ingestions when intensive supportive care was provided.

Prognostic limitation

The historical claim that survival beyond five hours guarantees a good outcome is too simplistic.

Prognosis depends on the extent of hypoxic injury, the duration of spasms, organ complications, and the quality of supportive care.

30. Prevention

Pesticides

Store all pest-control chemicals in original labeled containers, secured against access by children or unauthorized individuals.

Traditional preparations

Avoid medicinal products containing strychnine or nux vomica unless their safety and legal status have been properly established.

Laboratory safety

Use appropriate chemical-handling procedures and protective equipment.

Illicit drug exposure

Unregulated substances may contain unexpected toxic contaminants.

Household safety

Dispose of obsolete medications and pesticides through appropriate local hazardous-waste or medicine-disposal programs.

31. Clinical pitfalls

Failing to recognize awake convulsions. Preserved awareness during generalized spasms is a critical diagnostic clue.

Assuming all generalized convulsions are epileptic seizures. Strychnine causes spinal and brainstem motor-neuron disinhibition.

Ignoring stimulus sensitivity. Touch, noise, light, and procedures may provoke severe spasms.

Overlooking tetanus. The syndromes overlap but differ in onset and persistence of rigidity.

Assuming a patient who can speak between episodes is safe. Respiratory arrest may occur during the next spasm.

Delaying benzodiazepines. Uncontrolled muscular activity can produce fatal hypoxia, hyperthermia, and acidosis.

Repeatedly using phenytoin for toxin-induced spasms. Sedation and, when required, neuromuscular blockade address the syndrome more directly.

Delaying intubation in severe recurrent spasms. Airway management may become increasingly difficult as contractions worsen.

Using neuromuscular paralysis without adequate sedation. The patient may remain conscious and aware.

Performing routine gastric lavage. Instrumentation may provoke spasms and aspiration.

Administering charcoal before airway protection. Rapid deterioration creates substantial aspiration risk.

Relying on a serum strychnine level before treatment. Laboratory confirmation is usually unavailable when decisions are needed.

Ignoring temperature and creatine kinase. Hyperthermia and rhabdomyolysis can evolve rapidly.

Assuming lactic acidosis requires bicarbonate as primary treatment. Control of spasms and correction of hypoxia are more important.

Using urinary acidification or forced diuresis. These are not recommended and may cause harm.

Using hemodialysis solely to remove strychnine. Enhanced elimination is not an established indication.

Applying a rigid four-hour or six-hour observation rule. Delayed presentations can occur, especially with some plant preparations.

Assuming survival after the initial hours excludes later complications. Muscle and kidney injury may become more apparent during recovery.


Key clinical conclusions

Strychnine is a potent glycine-receptor antagonist that causes extreme spinal and brainstem motor-neuron excitation.

The hallmark of poisoning is recurrent, extremely painful tonic spasms triggered by minor sensory stimuli, often with preserved consciousness and no postictal phase.

Respiratory muscle spasm and asphyxia represent the most immediate threats to life.

Benzodiazepines are first-line treatment. Severe poisoning may require deep sedation, endotracheal intubation, mechanical ventilation, and nondepolarizing neuromuscular blockade.

Active cooling and management of lactic acidosis, rhabdomyolysis, electrolyte disturbances, and kidney injury are essential.

There is no specific antidote. Activated charcoal may be considered selectively after airway protection, while routine gastric lavage, induced vomiting, urinary acidification, and dialysis for drug removal are not recommended.

Rapid control of muscle activity and effective ventilation are the most important determinants of survival.



Image description
0 Comments